STOCK TITAN

Seer to Participate in the TD Cowen 44th Annual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Seer, Inc. (SEER) will be participating in the TD Cowen 44th Annual Health Care Conference in Boston, MA. Seer's management will engage in a fireside chat and Q&A session on March 4th. A live webcast and archived replay will be accessible on Seer's investor website.
Positive
  • None.
Negative
  • None.

REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming TD Cowen 44th Annual Health Care Conference in Boston, MA.

Seer’s management is scheduled to participate in a fireside chat and Q&A session on Monday, March 4th at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time. A live webcast of the session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.

About Seer
Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Investor Contact:
Carrie Mendivil
investor@seer.bio

Media Inquiries:
Patrick Schmidt
pr@seer.bio


FAQ

When is Seer, Inc. participating in the TD Cowen 44th Annual Health Care Conference?

Seer, Inc. will be participating in the TD Cowen 44th Annual Health Care Conference on March 4th.

What time is Seer, Inc.'s fireside chat and Q&A session scheduled for?

Seer, Inc.'s fireside chat and Q&A session is scheduled for 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time on March 4th.

Where can investors watch the live webcast of Seer, Inc.'s session at the conference?

Investors can watch the live webcast of Seer, Inc.'s session on the Investor section of Seer's website at investor.seer.bio.

Will there be an archived replay available for Seer, Inc.'s session?

Yes, an archived replay will be available on Seer, Inc.'s website following the conference.

Seer, Inc.

NASDAQ:SEER

SEER Rankings

SEER Latest News

SEER Stock Data

145.46M
46.94M
7.25%
71.38%
4.26%
Testing Laboratories
Professional, Scientific, and Technical Services
Link
United States of America
REDWOOD CITY

About SEER

seer, inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. the company develops proteograph product suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. it intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. seer, inc. has a collaboration program agreement with discovery life sciences, llc; and commercial agreements with bruker scientific llc and thermo electron north america llc. the company was formerly known as seer biosciences, inc. and changed its name to seer, inc. in july 2018. seer, inc. was incorporated in 2017 and is headquartered in redwood